Adel Jebar

581 total citations
9 papers, 457 citations indexed

About

Adel Jebar is a scholar working on Genetics, Infectious Diseases and Biotechnology. According to data from OpenAlex, Adel Jebar has authored 9 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 4 papers in Infectious Diseases and 4 papers in Biotechnology. Recurrent topics in Adel Jebar's work include Virus-based gene therapy research (7 papers), Viral gastroenteritis research and epidemiology (4 papers) and Cancer Research and Treatments (4 papers). Adel Jebar is often cited by papers focused on Virus-based gene therapy research (7 papers), Viral gastroenteritis research and epidemiology (4 papers) and Cancer Research and Treatments (4 papers). Adel Jebar collaborates with scholars based in United Kingdom, United States and Greece. Adel Jebar's co-authors include Margaret A. Knowles, Claire Taylor, Carolyn D. Hurst, Darren C. Tomlinson, C.F. Johnston, Peter Knapp, David K. Raynor, S.J. Price, Alan Melcher and Fiona Errington‐Mais and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Journal of General Virology.

In The Last Decade

Adel Jebar

9 papers receiving 440 citations

Peers

Adel Jebar

MB

SURGE

GENET

ONCOL

PRM

S. Srinivas United States

Juan Francisco González-Guerrero Mexico

Laura Vidal Spain

Robert Kruklitis United States

Jacklyn Liu United Kingdom

William H. Weir United States

Eric McLaughlin United States

Doreen William Germany

David Livingstone Alves Figueiredo Brazil

Mario Chan United Kingdom

S. Srinivas United States

Adel Jebar

94 ×0.4

MB

40 ×0.2

SURGE

81 ×0.7

GENET

125 ×1.4

ONCOL

50 ×0.9

PRM

Citations per year, relative to Adel Jebar Adel Jebar (= 1×) peers S. Srinivas

Countries citing papers authored by Adel Jebar

Since Specialization

Citations

This map shows the geographic impact of Adel Jebar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel Jebar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel Jebar more than expected).

Fields of papers citing papers by Adel Jebar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel Jebar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel Jebar. The network helps show where Adel Jebar may publish in the future.

Co-authorship network of co-authors of Adel Jebar

This figure shows the co-authorship network connecting the top 25 collaborators of Adel Jebar. A scholar is included among the top collaborators of Adel Jebar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adel Jebar. Adel Jebar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Jebar, Adel, Richard G. Vile, Alan Melcher, et al.. (2015). Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma. Journal of General Virology. 96(7). 1533–1550. 35 indexed citations

2.

Roulstone, Victoria, Malin Pedersen, Joan Kyula, et al.. (2015). BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress. Molecular Therapy. 23(5). 931–942. 38 indexed citations

3.

Jebar, Adel, Elizabeth J. Ilett, Tim Kottke, et al.. (2015). Abstract A49: Systemic oncolytic reovirus for the treatment of primary and secondary brain tumors. Cancer Immunology Research. 3(10_Supplement). A49–A49. 1 indexed citations

4.

Dave, Rajiv, Adel Jebar, Victoria A. Jennings, et al.. (2014). Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other viruses. The Surgeon. 12(4). 210–220. 8 indexed citations

5.

Jebar, Adel, Emma J. West, Karen J. Scott, et al.. (2014). P12 * A PHASE I TRIAL OF INTRAVENOUS ONCOLYTIC REOLYSIN(R) IN PATIENTS WITH BRAIN TUMOURS. Neuro-Oncology. 16(suppl 6). vi3–vi3. 2 indexed citations

6.

Jebar, Adel, Emma J. West, Karen J. Scott, et al.. (2014). Oncolytic wild-type reovirus infection in brain tumors following intravenous administration in patients.. Journal of Clinical Oncology. 32(15_suppl). 3104–3104. 3 indexed citations

7.

Twigger, Katie, Victoria Roulstone, Joan Kyula, et al.. (2012). Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer. 12(1). 368–368. 46 indexed citations

8.

Jebar, Adel, Carolyn D. Hurst, Darren C. Tomlinson, et al.. (2005). FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene. 24(33). 5218–5225. 265 indexed citations

9.

Knapp, Peter, David K. Raynor, Adel Jebar, & S.J. Price. (2005). Interpretation of Medication Pictograms by Adults in the UK. Annals of Pharmacotherapy. 39(7-8). 1227–1233. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact